早期尖部释放对比常规钬激光前列腺剜除术:术后尿失禁与功能结局的系统综述与荟萃分析
该系统综述与荟萃分析比较早期尖部释放(EAR)与常规HoLEP对术后尿失禁及功能结局的影响,纳入5项研究共2821例患者。EAR在术后4-6周及3-4个月降低SUI风险,6-12个月无显著差异;功能结局相当,EAR早期并发症(主要为Clavien-Dindo I-II级)更多但住院时间相似。
要点
- EAR在术后4-6周降低SUI风险(RR 0.47,95%CI 0.37-0.60)。
- EAR在3-4个月仍降低SUI风险(RR 0.44,95%CI 0.28-0.69),6-12个月无差异。
- 两组IPSS、QoL、Qmax、PVR及手术时间等指标相当。
核心结论
- EAR可减少HoLEP术后早期SUI,同时保持与常规HoLEP相当的功能结局。
研究设计与样本
- 遵循PRISMA指南的系统综述与荟萃分析,检索至2026年2月,纳入5项比较EAR与常规HoLEP的研究,共2821例患者。
- 采用Newcastle-Ottawa量表和Cochrane Risk of Bias-2工具评估质量,使用随机效应模型合并RR和MD及其95%CI,分析软件为RevMan 5.3。
主要发现
- 术后4-6周EAR组SUI风险更低(RR 0.47,95%CI 0.37-0.60;I²=0.0%)。
- 术后3-4个月EAR组SUI风险更低(RR 0.44,95%CI 0.28-0.69;I²=0%)。
- 术后6-12个月两组尿失禁无显著差异。
- EAR组术中及晚期术后并发症更少,但早期术后并发症更多,主要为Clavien-Dindo I-II级。
- 两组住院时间、IPSS、生活质量、Qmax、PVR、手术时间、剜除时间、粉碎时间及导尿管留置时间均相当。
临床怎么用
- EAR可作为HoLEP中优化早期尿控的技术改良,尤其关注术后早期SUI风险的患者。
- 需注意EAR可能增加早期低级别并发症,但住院时间未延长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite proven safety, efficacy, and durability of Holmium laser enucleation of the prostate (HoLEP), postoperative transient stress urine incontinence (SUI) was a concern for years. A technical modification of the original HoLEP, namely early apical release (EAR) has been suggested to reduce postoperative SUI. This study aimed to collate available evidence on the impact of EAR on the post HoLEP SUI and functional outcomes in comparison to conventional (non-EAR) HoLEP. METHODS: Following PRISMA guidelines, a comprehensive literature search was performed until February 2026. The Search focused on studies comparing EAR with conventional HoLEP. The primary outcome was the impact of each technique on SUI. Two reviewers independently screened studies, extracted data, and assessed quality using the Newcastle-Ottawa Scale and Cochrane Risk of Bias-2 tool. Pooled risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs) were estimated using random-effects models. Analyses were performed using RevMan 5.3. RESULTS: Five studies with 2821 patients were analyzed. EAR showed a lower risk of early SUI at 4-6 weeks (RR0.47, 95%CI 0.37-0.60; I² = 0.0%). At mid-term follow-up, 3-4 months, EAR was associated with lower risk of SUI (RR 0.44, 95%CI 0.28-0.69; I² = 0%). At 6-12 months, there were no significant differences in urinary incontinence. EAR had fewer intraoperative and late postoperative complications. However, EAR showed more early postoperative complications, mainly Clavien-Dindo grade I-II. Despite this, hospital stay was similar between both groups. Functional outcomes, including IPSS, quality of life, Qmax, and PVR, were comparable between groups throughout follow-up. Lastly, Operative time, enucleation time, morcellation time, and catheter duration were also comparable. CONCLUSION: EAR reduces early SUI while maintaining comparable functional outcomes compared to conventional HoLEP. These findings indicate EAR is an effective continence-optimizing modification during HoLEP.
引用
- Mansour I, Shaheen M, Elkenany AJ, et al. Early apical release versus conventional (non-early apical release) holmium laser enucleation of the prostate: a systematic review and meta-analysis of postoperative urinary incontinence and functional outcomes. Prostate Cancer Prostatic Dis. 2026. PMID: 42897208. doi:10.1038/s41391-026-01153-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。